Search Results - "Swisher, S."

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up by Kadara, H, Choi, M, Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Yoo, Y., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Wistuba, I.I., Herbst, R.S.

“…Lung adenocarcinomas (LUADs) lead to the majority of deaths attributable to lung cancer. We performed whole-exome sequencing (WES) and immune profiling…”
Get full text

A phase II randomized trial of induction chemotherapy versus no induction chemotherapy followed by preoperative chemoradiation in patients with esophageal cancer by Ajani, J.A., Xiao, L., Roth, J.A., Hofstetter, W.L., Walsh, G., Komaki, R., Liao, Z., Rice, D.C., Vaporciyan, A.A., Maru, D.M., Lee, J.H., Bhutani, M.S., Eid, A., Yao, J.C., Phan, A.P., Halpin, A., Suzuki, A., Taketa, T., Thall, P.F., Swisher, S.G.

“…The contribution of induction chemotherapy (IC) before preoperative chemoradiation for esophageal cancer (EC) is not known. We hypothesized that IC would…”
Get full text

Association between clinical complete response and pathological complete response after preoperative chemoradiation in patients with gastroesophageal cancer: analysis in a large cohort by Cheedella, N.K.S., Suzuki, A., Xiao, L., Hofstetter, W.L., Maru, D.M., Taketa, T., Sudo, K., Blum, M.A., Lin, S.H., Welch, J., Lee, J.H., Bhutani, M.S., Rice, D.C., Vaporciyan, A.A., Swisher, S.G., Ajani, J.A.

“…Chemoradiation followed by surgery is the preferred treatment of localized gastroesophageal cancer (GEC). Surgery causes considerable life-altering…”
Get full text

A multicenter study of survival after neoadjuvant radiotherapy/chemotherapy and esophagectomy for ypT0N0M0R0 esophageal cancer by Vallböhmer, D, Hölscher, Arnulf H, DeMeester, S, DeMeester, T, Salo, J, Peters, J, Lerut, T, Swisher, S G, Schröder, W, Bollschweiler, E, Hofstetter, W

“…To evaluate 5-year survival of patients with locally advanced esophageal cancer (LAEC) who have undergone multimodality treatment with complete histopathologic…”
Get full text

Mutation profiles in early-stage lung squamous cell carcinoma with clinical follow-up and correlation with markers of immune function by Choi, M., Kadara, H., Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Kim, K., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Herbst, R.S., Wistuba, I.I.

“…Lung squamous cell carcinoma (LUSC) accounts for 20–30% of non-small cell lung cancers (NSCLCs). There are limited treatment strategies for LUSC in part due to…”
Get full text

Comparative assessment of radiation therapy–induced vasculitis using [18F]FDG-PET/CT in patients with non-small cell lung cancer treated with proton versus photon radiotherapy by Evanson, D., Griffin, M., O’Reilly, S. E., Johnson, T., Werner, T., Kothekar, E., Jahangiri, P., Simone, C. B., Swisher-McClure, S., Feigenberg, S. J., Revheim, M.-E., Zou, J., Alavi, A.

“…Purpose To assess radiation therapy (RT)-induced vasculitis in patients with non-small cell lung cancer (NSCLC) by examining changes in the uptake of 18…”
Get full text

Clinical parameters model for predicting pathologic complete response following preoperative chemoradiation in patients with esophageal cancer by Ajani, J.A., Correa, A.M., Hofstetter, W.L., Rice, D.C., Blum, M.A., Suzuki, A., Taketa, T., Welsh, J., Lin, S.H., Lee, J.H., Bhutani, M.S., Ross, W.A., Maru, D.M., Macapinlac, H.A., Erasmus, J., Komaki, R., Mehran, R.J., Vaporciyan, A.A., Swisher, S.G.

“…Approximately 25% of patients with esophageal cancer (EC) who undergo preoperative chemoradiation, achieve a pathologic complete response (pathCR). We…”
Get full text

Analysis of trimodal and bimodal therapy in a selective-surgery paradigm for locally advanced oesophageal squamous cell carcinoma by Zhou, N, Mitchell, K G, Corsini, E M, Truong, V T T, Antonoff, M B, Mehran, R J, Rajaram, R, Rice, D C, Roth, J A, Sepesi, B, Swisher, S G, Vaporciyan, A A, Walsh, G L, Ajani, J A, Hofstetter, W L

“…Long-term survival outcomes of trimodal therapy (TMT; chemoradiation plus surgery) and bimodal therapy (BMT; chemoradiation) have seldom been analysed. In a…”
Get full text

Outcomes after surgical resection of cardiac sarcoma in the multimodality treatment era by Bakaeen, Faisal G., MD, Jaroszewski, Dawn E., MD, Rice, David C., MD, Walsh, Garret L., MD, Vaporciyan, Ara A., MD, Swisher, Steven S., MD, Benjamin, Robert, MD, Blackmon, Shanda, MD, Reardon, Michael J., MD

“…Objective Primary cardiac sarcomas are rare tumors carrying poor prognosis. Resection remains the primary therapy. Especially in recent years, chemotherapy and…”
Get full text

Worldwide esophageal cancer collaboration by Rice, T. W., Rusch, V. W., Apperson-Hansen, C., Allen, M. S., Chen, L.-Q., Hunter, J. G., Kesler, K. A., Law, S., Lerut, T. E. M. R., Reed, C. E., Salo, J. A., Scott, W. J., Swisher, S. G., Watson, T. J., Blackstone, E. H.

“…ABSTRACT The aim of this study is to report assemblage of a large multi‐institutional international database of esophageal cancer patients, patient and tumor…”
Get full text

Morbidity following salvage esophagectomy for squamous cell carcinoma: the MD Anderson experience by Mitchell, K G, Nelson, D B, Corsini, E M, Vaporciyan, A A, Antonoff, M B, Mehran, R J, Rice, D C, Roth, J A, Sepesi, B, Walsh, G L, Bhutani, M S, Maru, D M, Wu, C C, Nguyen, Q-N, Ajani, J A, Swisher, S G, Hofstetter, W L

“…SUMMARY The survival advantage associated with the addition of surgical therapy in esophageal squamous cell carcinoma (ESCC) patients who demonstrate a…”
Get full text

Radiographic response to neoadjuvant therapy in pleural mesothelioma should serve as a guide for patient selection for cytoreductive operations by Deboever, Nathaniel, Zhou, Nicolas, McGrail, Daniel J, Tomczak, Katarzyna, Oliva, Jacqueline L, Feldman, Hope A, Parra, Edwin, Zhang, Jianjun, Lee, Percy P, Antonoff, Mara B, Hofstetter, Wayne L, Mehran, Reza J, Rajaram, Ravi, Rice, David C, Roth, Jack A, Swisher, Stephen S, Vaporciyan, Ara A, Altan, Mehmet, Weissferdt, Annikka, Tsao, Anne S, Haymaker, Cara L, Sepesi, Boris

“…Malignant pleural mesothelioma (MPM) is associated with poor prognosis despite advances in multimodal therapeutic strategies. While patients with resectable…”
Get full text

Risk factors for local and regional recurrence in patients with resected N0–N1 non-small-cell lung cancer, with implications for patient selection for adjuvant radiation therapy by Lopez Guerra, J.L., Gomez, D.R., Lin, S.H., Levy, L.B., Zhuang, Y., Komaki, R., Jaen, J., Vaporciyan, A.A., Swisher, S.G., Cox, J.D., Liao, Z., Rice, D.C.

“…The purpose of this study was to evaluate the actuarial risk of local and regional failure in patients with completely resected non-small-cell lung cancer…”
Get full text

Genetic deletion of PKR abrogates TNF-induced activation of IκBα kinase, JNK, Akt and cell proliferation but potentiates p44/p42 MAPK and p38 MAPK activation by TAKADA, Y, ICHIKAWA, H, PATAER, A, SWISHER, S, AGGARWAL, B. B

“…Double-stranded RNA-dependent protein kinase (PKR), a ubiquitously expressed serine/threonine kinase, has been implicated in the regulation or modulation of…”
Get full text

Whole-exome sequencing and immune profiling of early-stage lung adenocarcinoma with fully annotated clinical follow-up by Kadara, H., Choi, M., Zhang, J., Parra, E.R., Rodriguez-Canales, J., Gaffney, S.G., Zhao, Z., Behrens, C., Fujimoto, J., Chow, C., Yoo, Y., Kalhor, N., Moran, C., Rimm, D., Swisher, S., Gibbons, D.L., Heymach, J., Kaftan, E., Townsend, J.P., Lynch, T.J., Schlessinger, J., Lee, J., Lifton, R.P., Wistuba, I.I., Herbst, R.S.

Get full text

Randomized phase II trial of osimertinib with or without local consolidation therapy (LCT) for patients with EGFR-mutant metastatic NSCLC (NORTHSTAR) by Elamin, Y.Y., Antonoff, M., Blakely, C., Baggstorm, M., Bivona, T., Le, X., Louie, A.V., Doebele, R.C., Rusthoven, C., Lee, P., Govindan, R., Swisher, S.G., Papadimitrakopoulou, V.A., Heymach, J.V., Gomez, D.R.

Get full text

Pathologic assessment following neoadjuvant immunotherapy or chemotherapy demonstrates similar patterns in non-small cell lung cancer (NSCLC) by Weissferdt, A., Sepesi, B., Pataer, A., Kalhor, N., Moran, C.A., William, W.N., Le, X., Glisson, B., Skoulidis, F., Blumenschein, G., Zhang, J., Altan, M., Rice, D., Mehran, R., Lee, J.J., Vaporciyan, A., Gibbons, D.L., Swisher, S.G., Heymach, J.V., Cascone, T.

Get full text

Results of the baseline positron emission tomography can customize therapy of localized esophageal adenocarcinoma patients who achieve a clinical complete response after chemoradiation by Suzuki, A., Xiao, L., Taketa, T., Sudo, K., Wadhwa, R., Blum, M.A., Skinner, H., Komaki, R., Weston, B., Lee, J.H., Bhutani, M.S., Rice, D.C., Maru, D.M., Erasmus, J., Swisher, S.G., Hofstetter, W.L., Ajani, J.A.

“…Patients with localized esophageal adenocarcinoma (EAC) who achieve a clinical complete response (clinCR) after preoperative chemoradiation (trimodality…”
Get full text

Contrast avoidance as a diagnostic feature of OCD: A receiver-operator characteristic curve analysis of the contrast avoidance questionnaires by Swisher, Valerie S., Newman, Michelle G.

“…Models focusing on transdiagnostic mechanisms, such as repetitive negative thinking, may be of additive value to existing conceptualizations of…”
Get full text

Adenovirus-Mediated p53 Gene Transfer in Sequence With Cisplatin to Tumors of Patients With Non–Small-Cell Lung Cancer by NEMUNAITIS, J, SWISHER, S. G, FOSSELLA, F, GLISSON, B. S, HONG, W. K, KHURI, F. R, KURIE, J. M, LEE, J. J, LEE, J. S, NGUYEN, D. M, NESBITT, J. C, PEREZ-SOLER, R, TIMMONS, T, PISTERS, K. M. W, PUTNAM, J. B, RICHLI, W. R, SHIN, D. M, WALSH, G. L, MERRITT, J, ROTH, J, CONNORS, D, MACK, M, DOERKSEN, L, WEILL, D, WAIT, J, LAWRENCE, D. D, KEMP, B. L

“…To determine the safety and tolerability of adenovirus-mediated p53 (Adp53) gene transfer in sequence with cisplatin when given by intratumor injection in…”
Get full text